Vimarsana
Biggest News Aggregation in the World

Page 18 - Science Summit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Science Summit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Science Summit Today - Breaking & Trending Today

COST: Breaking silos through global networking and international cooperation - Vimarsana News

COST: Breaking silos through global networking and international cooperation

Published: September 26, 2023

On 15 September 2023, as part of the Science Summit at the 78th United Nations General Assembly (UNGA78), COST co-organised a session with the U.S. National Science Foundation AccelNET Program, in New York City, to discuss global scientific networking collaboration. For the first time, this concrete initiative joins two funding schemes and their projects. International collaborative research 

Source: sciencebusiness.net
Related Topics:
New YorkUnited StatesRaphael HirschiAnne EmigAccelnet SustainfoodAccelnet IreChrysi LaspidouLuciano RezzollaUs National Science FoundationNational Science Foundation Accelnet ProgramUnited NationsScience SummitUnited Nations General AssemblyNational Science FoundationNew York CityRonald De BruinSection ChiefScience FoundationProf Luciano RezzollaTheoretical PhysicsWater Energy Food Nexus
Investigation of Novel Management Strategies Continues to Mitigate Disease-Related Toxicities Across Hematologic Malignancies - Vimarsana News

Investigation of Novel Management Strategies Continues to Mitigate Disease-Related Toxicities Across Hematologic Malignancies

Published: September 26, 2023

Amy W. Zhou, MD, highlights the unique mechanism of action of the JAK1/2 and ACVR1 inhibitor momelotinib and the importance of ongoing investigations of JAK inhibitor combination therapies in myelofibrosis.

Source: onclive.com
Related Topics:
United StatesWashington UniversityElaine MajerusPeter RiedellKristen SanfilippoAmyw ZhouWashington University School Of MedicineDepartment Of MedicineUniversity Of ChicagoDivision Of HematologyScience SummitWashington University SchoolSana Saif Ur RehmanJak Inhibitors In MyelofibrosisThe University Of ChicagoStephen OhWashington University School Of Medicine In St Louis
Value Research Center (vrc) At Ssunga78: Sept 25 At 16:00 Jst - Vimarsana News

Value Research Center (vrc) At Ssunga78: Sept 25 At 16:00 Jst

Published: September 25, 2023

Value Research Center (VRC) at SSUNGA78: 'How Purpose, Value, and Impact will Drive a Sustainable Post-SDG Future'

Source: briefingwire.com
Related Topics:
New YorkUnited StatesUnited KingdomToshiya HoshinoPhilip SugaiHaruko SatohMario AbelaValue Balancing AllianceCambridge Institute Of Sustainable LeadershipPermanent Mission Of JapanDoshisha UniversityAssembly Science SummitIntegration ResearchPanel DiscussionEducation CenterUnited NationsResearch CentreOkinawa Institute Of ScienceCambridge Institute For Sustainable LeadershipValue Research CenterOsaka UniversityResearch CenterHow PurposeScience SummitVictoria Hurth
Value Research Center (VRC) at SSUNGA78: 'How Purpose, Value, and Impact will Drive a Sustainable Post- SDG Future' - Vimarsana News

Value Research Center (VRC) at SSUNGA78: 'How Purpose, Value, and Impact will Drive a Sustainable Post- SDG Future'

Published: September 23, 2023

Value Research Center (VRC) at SSUNGA78: 'How Purpose, Value, and Impact will Drive a Sustainable Post- SDG Future'

Source: newsmaker.com.au
Related Topics:
United KingdomNew YorkUnited StatesHaruko SatohToshiya HoshinoPhilip SugaiMario AbelaResearch CentreOkinawa Institute Of ScienceEducation CenterPermanent Mission Of JapanValue Balancing AllianceOsaka UniversityIntegration ResearchAssembly Science SummitValue Research CenterDoshisha UniversityUnited NationsCambridge Institute Of Sustainable LeadershipCambridge Institute For Sustainable LeadershipVictoria HurthCambridge InstituteSustainable LeadershipScience SummitOkinawa Institute
Dr Esteva on the Use of CDK4/6 Inhibitors in HR+/HER2– Breast Cancer - Vimarsana News

Dr Esteva on the Use of CDK4/6 Inhibitors in HR+/HER2– Breast Cancer

Published: September 22, 2023

Francisco J. Esteva, MD, PhD, discusses the use of CDK4/6 inhibitors in patients with hormone receptor-positive/HER2-negative breast cancer.

Source: onclive.com
Related Topics:
Franciscoj EstevaPalbociclib IbranceDivision Of Hematology OncologyNorthwell HealthBreast Medical OncologyLenox Hill HospitalScience SummitBreast CancerOnclive Tv